# FDA Inspection 1064045 - GlaxoSmithKline Manufacturing S.p.A. - September 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/3e3eabdd-fb0e-4816-b71a-de1409ea4ed4
Source feed: FDA_Inspections

> FDA Inspection 1064045 for GlaxoSmithKline Manufacturing S.p.A. on September 29, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1064045
- Company Name: GlaxoSmithKline Manufacturing S.p.A.
- Inspection Date: 2017-09-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1285374 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/6fee4446-b8f0-4691-a877-618dc26c742b)
- [FDA Inspection 1244033 - 2023-10-26](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/c2a4825c-c374-4a17-8122-35913c30b269)
- [FDA Inspection 982333 - 2016-07-22](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/98e8f571-5a65-40f4-9600-4b7642f7db8d)
- [FDA Inspection 934049 - 2015-05-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/11cd01a9-b7be-4ff7-a6b9-3b7a7148d1b7)
- [FDA Inspection 842545 - 2013-07-10](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/37b4ba75-74c1-42b7-a9b2-b8350b905c1e)

Company: https://www.keypedia.com/companies/glaxosmithkline-manufacturing-spa/11f7427f-c02e-4b80-91dd-f90cbe9b90a9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c